1. Lalitha G., Salomi P., Ravindra R. K., Development of an analytical method and its validation for the analysis of atenolol in tablets dosage form by uv-spectrophotometry, IJPPS. 5(2), 197–99 (2013).
2. Borchard U., Pharmacological properties of beta-adrenoceptor blocking durgs. J Clin Bas Card. 1, 5–9 (1998).
3. The Indian Pharmacopoeia, Government of Indian ministry of health and familywelfare, The Indian Pharmacopoeia Commission, Ghaziabad, Vol I. I., 747–48. (2007).
4. The Merck index, An encyclopedia of chemicals, drugs and biological, 13th Edition, Merck research laboratories, Division of Merck and Co. Inc. White house station, NJ, Atenolol 863, 147 (2001).
5. Lalitha K. V., Jyothi R. K., Padma B. UV spectrophotometric method development and validation of atenolol and losartan potassium by q analysis. I Bull Drug Res, 3(4), 54–62 (2013).